Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. [electronic resource]
Producer: 20200331Description: 486-493 p. digitalISSN:- 1542-7714
- Adolescent
- Adult
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Calcineurin Inhibitors -- administration & dosage
- Cyclosporine -- administration & dosage
- Drug Therapy, Combination -- adverse effects
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Gastrointestinal Agents -- administration & dosage
- Humans
- Inflammatory Bowel Diseases -- drug therapy
- Male
- Prospective Studies
- Tacrolimus -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.